ZALICUS
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010... , the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.
ZALICUS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.zalicus.com
Total Employee:
11+
Status:
Active
Contact:
6173017010
Total Funding:
84.98 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon California Region
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Nocion Therapeutics
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-21 | Neuromed Pharmaceuticals | Neuromed Pharmaceuticals acquired by Zalicus | N/A |
Investors List
TL Ventures
TL Ventures investment in Series E - Zalicus
Flagship Pioneering
Flagship Pioneering investment in Series D - Zalicus
Easton Capital
Easton Capital investment in Series D - Zalicus
Global Life Science Ventures
Global Life Science Ventures investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series D - Zalicus
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series D - Zalicus
TL Ventures
TL Ventures investment in Series D - Zalicus
Boston Millennia Partners
Boston Millennia Partners investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series C - Zalicus
TL Ventures
TL Ventures investment in Series C - Zalicus
Official Site Inspections
http://www.zalicus.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Zalicus"
Zalicus Company Profile 2024: Valuation, Investors, …
Zalicus General Information Description. Developer of treatments for pain and inflammation drugs based in Cambridge, Massachusetts. The company applies ion-channel modulation expertise to discover therapeutics for both internal …See details»
Zalicus Company Profile | Management and Employees List
Zalicus has a portfolio of proprietary clinical-stage product candidates targeting pain and has entered into multiple revenue-generating collaborations with large pharmaceutical companies …See details»
Zalicus Management Team | Org Chart - RocketReach
The Zalicus management team includes Elias Nyberg (Vice President Regulatory), Mike Nelson (Vice President, Clinical Operations), and Zhi-Yi Zhang (Team Leader). Get Contact Info for All …See details»
Zalicus - Products, Competitors, Financials, Employees, …
Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease …See details»
ZALICUS INC. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ZALICUS INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Zalicus Incorporated - Company Profile & Staff Directory
Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. Zalicus has a portfolio of proprietary clinical-stage product candidates …See details»
Zalicus Pharmaceuticals - Crunchbase Company Profile & Funding
Zalicus Pharmaceuticals is located in Vancouver, British Columbia, Canada. Who are Zalicus Pharmaceuticals 's competitors? Alternatives and possible competitors to Zalicus …See details»
Zalicus Inc. - VentureRadar
Zalicus Inc., is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immune-inflammatory diseases. The company applies its …See details»
Zalicus - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Zalicus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Zalicus: Contact Details and Business Profile - RocketReach
The NAICS codes for Zalicus are [32541, 3254, 325, 32, 325412]. What is the SIC code for Zalicus? The SIC codes for Zalicus are [283, 28]. Top Zalicus Employees Elias Nyberg Vice …See details»
Zalicus | Scientist.com
Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. Zalicus applies its expertise in the discovery and development of selective …See details»
U.S. arm of Sun Pharma's Taro buys Zalicus ... - Fierce Pharma
Oct 14, 2015 The acquisition of Canada's Zalicus Pharmaceuticals by a U.S. subsidiary of India's largest drugmaker, Sun Pharmaceuticals, is being seen as a move to strengthen its …See details»
Zalicus - Crunchbase
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»
Zalicus - Overview, News & Similar companies | ZoomInfo.com
Jun 18, 2014 Zalicus. Manufacturing · Massachusetts, United States · 70 Employees. View Company Info for Free. About. Headquarters 245 1st St Ste 3, Cambridge, Massachusetts, …See details»
Zalicus, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Zalicus, Inc. with its drug pipeline, therapeutic area, technology platform, 22 clinical trials, 13 news, and 35 literature, Disease Domain:Endocrinology and ...See details»
Zalicus Pharmaceuticals - PitchBook
Zalicus Pharmaceuticals General Information Description. Developer of chronic pain drugs. The company's pain management drugs target neuronal calcium channels to treat neurological …See details»
Zalicus - Company Profile - Tracxn
Nov 1, 2024 Zalicus ranks 21st among 237 active competitors. 68 of its competitors are funded while 66 have exited. Overall, Zalicus and its competitors have raised over $4.46B in funding …See details»
Zalicus - Funding, Financials, Valuation & Investors - Crunchbase
Zalicus is registered under the ticker NASDAQ:CRXX . Their stock opened with $7.00 in its Nov 9, 2005 IPO. Zalicus is funded by 7 investors. TL Ventures and Flagship Pioneering are the most …See details»
Articles about Zalicus Inc. - BioSpace
Oct 30, 2013 About Zalicus Inc. Zalicus (Nasdaq: ZLCS) is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno …See details»